Jeffrey M. Dayno insider trades

Open-market stock purchases and sales by Jeffrey M. Dayno, PRESIDENT, CEO at Harmony Biosciences Holdings, Inc, from SEC Form 4 filings since Aug 6, 2014.

Recent trades

DateStockTradeValue
Jan 25, 2026HRMY Harmony Biosciences Holdings, IncSold (not open market)$208K
Jan 25, 2026HRMY Harmony Biosciences Holdings, IncBought (not open market)—
Jan 24, 2026HRMY Harmony Biosciences Holdings, IncSold (not open market)$176K
Jan 24, 2026HRMY Harmony Biosciences Holdings, IncBought (not open market)—
Jan 22, 2026HRMY Harmony Biosciences Holdings, IncBought (not open market)—
Jan 22, 2026HRMY Harmony Biosciences Holdings, IncBought (not open market)—
Dec 12, 2025HRMY Harmony Biosciences Holdings, IncSold$802K
Dec 12, 2025HRMY Harmony Biosciences Holdings, IncSold$238K
Dec 12, 2025HRMY Harmony Biosciences Holdings, IncBought (not open market)—

Companies traded

  • HRMY Harmony Biosciences Holdings, Inc: 13 sales, last Jan 25, 2026
  • EGLT Egalet Corp: 9 sales, last Jun 8, 2017

Get free alerts when Jeffrey M. Dayno files a new trade →